CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 120 enrolled
Drug / intervention
Dexcom G6device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05394844
NCT05394844N/ACompleted
CompareCT.gov

Study of a Culturally Tailored Diabetes Education Curriculum With Real-time Continuous Glucose Monitoring in a Latinx Population With Type 2 Diabetes (The CUTDM With CGM Study)

University of Washington·interventional·Posted May 27, 2022·Updated Dec 1, 2025

In Brief

A clinical study evaluating Dexcom G6 for Diabetes Type 2. Completed, enrolled 120 participants across 2 sites.

Detailed Summary

Determine the impact of the Compañeros en Salud (Partners in Health) curriculum in conjunction with RT-CGM on glycemic control in Latinx patients with T2D. Participants will be randomized to receive the Companeros en Salud diabetes self-management education and support (DSMES) intervention with or without RT-CGM

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Type 2
CountriesUnited States
CollaboratorsAmerican Diabetes Association, Washington State University, Sea Mar Community Health Centers, DexCom, Inc.

Timeline

N/ACompletedFinished
2023202420252026
First PostedMay 27, 2022
Enrollment StartNov 11, 2022
Primary CompletionJul 30, 2024
Study CompletionNov 30, 2024
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 4.1 years ago

Interventions

Dexcom G6device

Dexcom G6 CGM device